ArticlePDF Available

Expression of Concern: Walach et al. The Safety of COVID-19 Vaccinations—We Should Rethink the Policy. Vaccines 2021, 9, 693

Authors:

Abstract

The journal is issuing this expression of concern to alert readers to significant concerns regarding the paper cited above [...]
Vaccines 2021, 9, 705. https://doi.org/10.3390/vaccines9070705 www.mdpi.com/journal/vaccines
Expression of Concern
Expression of Concern: Walach et al. The Safety of
COVID-19 Vaccinations—We Should Rethink the Policy.
Vaccines 2021, 9, 693
Vaccines Editorial Office
MDPI, St. Alban-Anlage 66, 4052 Basel, Switzerland; vaccines@mdpi.com
The journal is issuing this expression of concern to alert readers to significant con-
cerns regarding the paper cited above [1].
Serious concerns have been raised about misinterpretation of the data and the con-
clusions.
The major concern is the misrepresentation of the COVID-19 vaccination efforts and
misrepresentation of the data, e.g., Abstract: “For three deaths prevented by vaccination
we have to accept two > inflicted by vaccination”. Stating that these deaths linked to vac-
cination efforts is incorrect and distorted.
We will provide an update following theconclusion of our investigation. The authors
have been notified about this Expression of Concern.
Reference
1. Walach, H.; Klement, R.J.; Aukema, W. The Safety of COVID-19 Vaccinations—We Should Re-
think the Policy. Vaccines 2021, 9, 693, doi:10.3390/vaccines9070693.
Citation: Vaccines Editorial Office.
Expression of Concern: Walach et al.
The Safety of COVID-19
Vaccinations—We Should Rethink
the Policy. Vaccines 2021, 9, 693.
Vaccines 2021, 9, 705. https://doi.org/
10.3390/vaccines9070705
Received: 28 June 2021
Accepted: 28 June 2021
Published: 28 June 2021
Publisher’s Note: MDPI stays neu-
tral with regard to jurisdictional
claims in published maps and institu-
tional affiliations.
Copyright: © 2021 by the authors.
Submitted for possible open access
publication under the terms and con-
ditions of the Creative Commons At-
tribution (CC BY) license (http://crea-
tivecommons.org/licenses/by/4.0/).
Preprint
Full-text available
U hrvatskim je medijima sve više govora o cijepljenju djece protiv covid-19, unatoč maloj ulozi djece u prijenosu novog koronavirusa i njihovom malom riziku od teških simptoma, postojanju drugih oblika prevencije, činjenici da klinička ispitivanja nisu dovršena, raznih problema u provedenim ispitivanjima i rastućoj zabrinutosti oko sigurnosti cjepiva i mogućih štetnih učinaka. Cilj je ovog kratkog pregleda odabrane znanstvene literature potaknuti kvalitetnu javnu raspravu prije donošenja potencijalno ishitrenih odluka.
Article
Full-text available
Background: COVID-19 vaccines have had expedited reviews without sufficient safety data. We wanted to compare risks and benefits. Method: We calculated the number needed to vaccinate (NNTV) from a large Israeli field study to prevent one death. We accessed the Adverse Drug Reactions (ADR) database of the European Medicines Agency and of the Dutch National Register (lareb.nl) to extract the number of cases reporting severe side effects and the number of cases with fatal side effects. Result: The NNTV is between 200–700 to prevent one case of COVID-19 for the mRNA vaccine marketed by Pfizer, while the NNTV to prevent one death is between 9000 and 50,000 (95% confidence interval), with 16,000 as a point estimate. The number of cases experiencing adverse reactions has been reported to be 700 per 100,000 vaccinations. Currently, we see 16 serious side effects per 100,000 vaccinations, and the number of fatal side effects is at 4.11/100,000 vaccinations. For three deaths prevented by vaccination we have to accept two inflicted by vaccination. Conclusions: This lack of clear benefit should cause governments to rethink their vaccination policy.